How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Sell
26
DCGO Quote, Financials, Valuation and Earnings
Last price:
$1.59
Seasonality move
:
0.98%
Day range:
$1.58 - $1.67
52-week range:
$1.23 - $5.68
Dividend yield:
0%
P/E ratio:
8.24x
P/S ratio:
0.33x
P/B ratio:
0.51x
Volume:
1.2M
Avg. volume:
1.4M
1-year change:
-48.38%
Market cap:
$157.6M
Revenue:
$616.6M
EPS (TTM):
-$0.02
Analysts' Opinion
-
Consensus RatingDocGo has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.05, DocGo has an estimated upside of 91.82% from its current price of $1.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.45 representing 100% downside risk from its current price of $1.59.
Fair Value
-
According to the consensus of 6 analysts, DocGo has 91.82% upside to fair value with a price target of $3.05 per share.
DCGO vs. S&P 500
-
Over the past 5 trading days, DocGo has overperformed the S&P 500 by 5.46% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
DocGo does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DocGo revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter DocGo reported revenues of $96M.
Earnings Growth
-
DocGo has grown year-over-year earnings for 0 quarters straight. In the most recent quarter DocGo reported earnings per share of -$0.09.
Enterprise value:
101.2M
EV / Invested capital:
--
Price / LTM sales:
0.33x
EV / EBIT:
2.76x
EV / Revenue:
0.19x
PEG ratio (5yr expected):
0.06x
EV / Free cash flow:
1.20x
Price / Operating cash flow:
2.03x
Enterprise value / EBITDA:
6.83x
Gross Profit (TTM):
$177.1M
Return On Assets:
-0.14%
Net Income Margin (TTM):
-0.12%
Return On Equity:
-0.2%
Return On Invested Capital:
-0.19%
Operating Margin:
-14.58%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $435.6M | $703.4M | $520.5M | $192.1M | $96M | |
| Gross Profit | $146.6M | $230.9M | $177.1M | $67.3M | $30.8M | |
| Operating Income | $4.8M | $37.8M | -$1.2M | $15.9M | -$14M | |
| EBITDA | $16.8M | $55M | $14.8M | $20.3M | -$10.6M | |
| Diluted EPS | $0.19 | $0.20 | -$0.02 | $0.10 | -$0.09 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $268.2M | $258.4M | $335.1M | $262.5M | |
| Total Assets | -- | $325.2M | $407.5M | $490.7M | $430.8M | |
| Current Liabilities | -- | $61M | $109M | $160.1M | $107.6M | |
| Total Liabilities | -- | $84.9M | $123.6M | $175.6M | $128.9M | |
| Total Equity | -- | $240.3M | $283.9M | $315.1M | $301.9M | |
| Total Debt | -- | $2.8M | $1.9M | $30.1M | $30M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$12.5M | -$51.7M | $90.6M | -$10.6M | $9.7M | |
| Cash From Investing | -$39M | -$29.9M | -$14.9M | -$1.7M | -$5.7M | |
| Cash From Financing | -$20.6M | $12.2M | -$31.8M | -$881.6K | -$8.5M | |
| Free Cash Flow | -$20.3M | -$60.2M | $84.3M | -$12.4M | $7.5M | |
DCGO
Sector
Market Cap
$157.6M
$32.8M
Price % of 52-Week High
28.02%
46.34%
Dividend Yield
0%
0%
Shareholder Yield
5.16%
-0.74%
1-Year Price Total Return
-48.38%
-35.67%
Beta (5-Year)
--
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.55
200-day SMA
Sell
Level
$3.32
Bollinger Bands (100)
Sell
Level
1.49 - 4.11
Chaikin Money Flow
Sell
Level
-11M
20-day SMA
Buy
Level
$1.48
Relative Strength Index (RSI14)
Sell
Level
48.98
ADX Line
Buy
Level
20.41
Williams %R
Neutral
Level
-33.3333
50-day SMA
Sell
Level
$1.80
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Sell
Level
-7.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.891)
Buy
CA Score
(Annual)
Level (1.0514)
Buy
Beneish M-Score
(Annual)
Level (-3.2234)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.7272)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
Stock Forecast FAQ
In the current month, DCGO has received 3 Buy ratings 3 Hold ratings, and 0 Sell ratings. The DCGO average analyst price target in the past 3 months is $3.05.
-
Where Will DocGo Stock Be In 1 Year?
According to analysts, the consensus estimate is that DocGo share price will rise to $3.05 per share over the next 12 months.
-
What Do Analysts Say About DocGo?
Analysts are divided on their view about DocGo share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DocGo is a Sell and believe this share price will drop from its current level to $1.45.
-
What Is DocGo's Price Target?
The price target for DocGo over the next 1-year time period is forecast to be $3.05 according to 6 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is DCGO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DocGo is a Leans Bullish. 3 of 6 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of DCGO?
You can purchase shares of DocGo via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DocGo shares.
-
What Is The DocGo Share Price Today?
DocGo was last trading at $1.59 per share. This represents the most recent stock quote for DocGo. Yesterday, DocGo closed at $1.59 per share.
-
How To Buy DocGo Stock Online?
In order to purchase DocGo stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Target’s Stock Be in 10 Years?
If you could hop into a time machine and land…
Why Did Stan Druckenmiller Buy DocuSign?
Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
37
RGC alert for Jun 21
Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.
Buy
83
GMS alert for Jun 21
GMS [GMS] is up 23.79% over the past day.
Buy
57
QNTM alert for Jun 21
Quantum BioPharma [QNTM] is up 13.82% over the past day.
